Premium
Clinical investigation of 38 cases of oral mucosal melanoma: A multicentre retrospective analysis in Japan
Author(s) -
Yamada Shinichi,
Kurita Hiroshi,
Kamata Takahiro,
Kirita Tadaaki,
Ueda Michihiro,
Yamashita Tetsuro,
Ota Yoshihide,
Otsuru Mitsunobu,
Yamakawa Nobuhiro,
Okura Masaya,
Aikawa Tomonao,
Yanamoto Souichi,
Umeda Masahiro
Publication year - 2017
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.12603
Subject(s) - medicine , stage (stratigraphy) , mucosal melanoma , retrospective cohort study , melanoma , surgery , pathological , radical surgery , survival rate , cancer , paleontology , cancer research , biology
Background/Objectives The aim of the present study was to investigate treatment modalities and outcomes in oral mucosal melanoma. Methods The clinical and pathological data of 38 consecutive patients with oral mucosal melanoma were retrospectively analyzed. Patients' characteristics were analyzed and overall survival (OS) rates were calculated. Results Sixteen patients had stage III (42%), 19 IVA (50%), and three had stage IVC (8%) disease. Among the therapeutic approaches used, 31 patients (82%) received radical therapy (surgery +/− chemotherapy). The 5‐year OS rate was 40%. Five‐year OS rates according to the clinical stage were 71% for stage III, 24% for stage IVA, and 0% for stage IVC. Five‐year OS rates according to therapeutic approaches were 52% in the radical therapy group and 0% in the palliative therapy and best supportive care groups. Conclusions The results of this multicentre retrospective analysis of patients with oral mucosal melanoma suggest that radical therapy based on surgical treatments with complete surgical excision with clear margins leads to a better prognosis.